Almonertinib Plus Microwave Ablation Versus Almonertinib in Previously Untreated Advanced Non-small Cell Lung Cancer, a Randomized Controlled Phase II Clinical Trial
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Aumolertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms MWA
- 02 Sep 2021 Planned initiation date changed from 1 Jul 2021 to 1 Jan 2022.
- 15 Jun 2021 Planned initiation date changed from 1 Apr 2021 to 1 Jul 2021.
- 17 Feb 2021 New trial record